DE2822727A1 - Therapeutisches mittel gegen geschwuere des verdauungstraktes - Google Patents

Therapeutisches mittel gegen geschwuere des verdauungstraktes

Info

Publication number
DE2822727A1
DE2822727A1 DE19782822727 DE2822727A DE2822727A1 DE 2822727 A1 DE2822727 A1 DE 2822727A1 DE 19782822727 DE19782822727 DE 19782822727 DE 2822727 A DE2822727 A DE 2822727A DE 2822727 A1 DE2822727 A1 DE 2822727A1
Authority
DE
Germany
Prior art keywords
therapeutic agent
compound
found
calculated
digestive tract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19782822727
Other languages
German (de)
English (en)
Other versions
DE2822727C2 (US06826419-20041130-M00005.png
Inventor
Yuichi Inai
Shizumasa Kijima
Manabu Murskami
Toshiharu Ohgoh
Isao Yamatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of DE2822727A1 publication Critical patent/DE2822727A1/de
Application granted granted Critical
Publication of DE2822727C2 publication Critical patent/DE2822727C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/62—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C07C45/676—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton by elimination of carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Polymers & Plastics (AREA)
DE19782822727 1977-05-26 1978-05-24 Therapeutisches mittel gegen geschwuere des verdauungstraktes Granted DE2822727A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6042777A JPS53145922A (en) 1977-05-26 1977-05-26 Remedy for peptic ulcer containing prenyl ketone compound

Publications (2)

Publication Number Publication Date
DE2822727A1 true DE2822727A1 (de) 1978-11-30
DE2822727C2 DE2822727C2 (US06826419-20041130-M00005.png) 1987-01-29

Family

ID=13141907

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782822727 Granted DE2822727A1 (de) 1977-05-26 1978-05-24 Therapeutisches mittel gegen geschwuere des verdauungstraktes

Country Status (8)

Country Link
US (1) US4169157A (US06826419-20041130-M00005.png)
JP (1) JPS53145922A (US06826419-20041130-M00005.png)
BE (1) BE867423A (US06826419-20041130-M00005.png)
DE (1) DE2822727A1 (US06826419-20041130-M00005.png)
FR (1) FR2391723A1 (US06826419-20041130-M00005.png)
GB (1) GB1602566A (US06826419-20041130-M00005.png)
PH (1) PH13999A (US06826419-20041130-M00005.png)
SE (1) SE7805990L (US06826419-20041130-M00005.png)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5742643A (en) * 1980-08-29 1982-03-10 Eisai Co Ltd 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraene-2-ol
JPS5772933A (en) * 1980-10-23 1982-05-07 Agency Of Ind Science & Technol Polyprenylketone derivative and its preparatio
GB2122610B (en) * 1982-05-28 1987-04-01 Eisai Co Ltd A polyprenyl compound and a pharmaceutical composition containing a polyprenyl compound
JPH07103019B2 (ja) * 1985-07-04 1995-11-08 エーザイ株式会社 胃炎治療・予防剤
JP2708126B2 (ja) * 1987-08-25 1998-02-04 日清製粉株式会社 イソプレノイド誘導体とそれを含有する抗潰瘍剤
JP4632480B2 (ja) * 2000-05-16 2011-02-16 レドックス・バイオサイエンス株式会社 チオレドキシン誘導物質
US20040249219A1 (en) * 2000-07-05 2004-12-09 Saucy Gabriel G. Method of making teprenone
WO2002098398A1 (en) * 2001-06-07 2002-12-12 Eisai Co., Ltd. Methods for preventing and treating diseases and conditions associated with cellular stress
US6846845B2 (en) 2002-01-09 2005-01-25 Naohiko Takahashi Heat shock protein inducer
KR100686300B1 (ko) * 2002-11-22 2007-02-26 에자이 가부시키가이샤 테프레논을 충전한 히드록시프로필메틸셀룰로오스 캡슐제제
KR101233879B1 (ko) 2004-01-16 2013-02-15 칼 짜이스 에스엠티 게엠베하 편광변조 광학소자
US20110237537A1 (en) * 2009-05-29 2011-09-29 Lombard Jay L Methods for assessment and treatment of mood disorders via single nucleotide polymorphisms analysis
US8355927B2 (en) 2010-11-05 2013-01-15 Genomind, Llc Neuropsychiatric test reports
EP2423177A1 (en) * 2010-08-25 2012-02-29 Nyken Holding B.V. Analogs of geranylgeranylacetone (GGA)
CA2850716A1 (en) * 2011-10-04 2013-04-11 Coyote Pharmaceuticals, Inc. Geranylgeranylacetone derivatives
US9045403B2 (en) 2012-02-29 2015-06-02 Coyote Pharmaceuticals, Inc. Geranyl geranyl acetone (GGA) derivatives and compositions thereof
WO2013157926A1 (en) 2012-04-19 2013-10-24 Nyken Holding B.V. Geranyl geranyl acetone analogs and uses thereof
US9119808B1 (en) 2012-10-08 2015-09-01 Coyote Pharmaceuticals, Inc. Treating neurodegenerative diseases with GGA or a derivative thereof
CN105732340A (zh) * 2016-04-15 2016-07-06 四川墨凯科技有限公司 一种替普瑞酮的合成工艺
CN105859524A (zh) * 2016-04-15 2016-08-17 四川墨凯科技有限公司 一种反式，反式-金合欢醇的合成方法
EP3445384B1 (en) 2016-04-21 2023-07-12 Stichting VUmc Composition for treating diastolic dysfunction
CN107501070B (zh) * 2016-06-14 2022-03-11 成都国为生物医药有限公司 一种替普瑞酮的精制方法及其中间体
CN109574821B (zh) * 2018-11-06 2021-12-28 黄冈鲁班药业股份有限公司 一种替普瑞酮合成的中间体及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429970A (en) * 1961-02-02 1969-02-25 Hoffmann La Roche Method of hindering the metamorphosis and reproduction of arthropodes
GB938712A (en) * 1961-05-24 1963-10-02 Angeli Inst Spa Farnesyl acetic esters
FR1363573A (fr) * 1963-06-27 1964-06-12 Hoffmann La Roche Procédé pour la préparation de cétones oléfiniques
US3824319A (en) * 1971-01-07 1974-07-16 Us Agriculture Arthropod maturation inhibition employing certain epoxy compounds
US3729486A (en) * 1971-02-01 1973-04-24 Zoecon Corp Epithio di-unsaturated aliphatic ketones and aldehydes
US3978230A (en) * 1974-01-24 1976-08-31 The United States Of America As Represented By The Secretary Of Agriculture Arthropod maturation inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT *

Also Published As

Publication number Publication date
GB1602566A (en) 1981-11-11
SE7805990L (sv) 1978-11-27
FR2391723A1 (fr) 1978-12-22
DE2822727C2 (US06826419-20041130-M00005.png) 1987-01-29
FR2391723B1 (US06826419-20041130-M00005.png) 1984-11-02
BE867423A (fr) 1978-09-18
JPS6344726B2 (US06826419-20041130-M00005.png) 1988-09-06
US4169157A (en) 1979-09-25
PH13999A (en) 1980-11-28
JPS53145922A (en) 1978-12-19

Similar Documents

Publication Publication Date Title
DE2822727A1 (de) Therapeutisches mittel gegen geschwuere des verdauungstraktes
DE2915318C2 (US06826419-20041130-M00005.png)
EP0396069B1 (de) Salze des Azelastins mit verbesserter Löslichkeit
AT389871B (de) Verfahren zur herstellung von beta, gamma -dihydropolyprenylalkoholderivaten
DE2160148C2 (de) Arzneimittel und bestimmte Sulfoxide als solche
DE2759171A1 (de) Arzneimittel mit wirkung als prostaglandinsynthetaseninhibitor
AT391689B (de) Verfahren zur herstellung von neuen 4-phenyl-4-oxo-2-butensaeurederivaten und von deren salzen
DE2926463C2 (US06826419-20041130-M00005.png)
EP0132811A1 (de) In 1-Stellung substituierte 4-Hydroxymethyl-pyrrolidinone, Verfahren zu ihrer Herstellung, pharmazeutische Zusammensetzungen und Zwischenprodukte
EP0006114A1 (de) 7-Methoxy-5-oxo-5H-thiazolo(2,3-b)chinazolin-2-carbonsäure und deren pharmazeutisch verwendbare Salze. Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
DE2252637A1 (de) Choleretische arzneimittel
DE2804293C2 (US06826419-20041130-M00005.png)
DE2336670A1 (de) Aminoaether von o-thymotinsaeureestern
DE2833067A1 (de) Pyranochromonderivate und antiallergika, welche diese enthalten
DE2947775C2 (US06826419-20041130-M00005.png)
DE2264938A1 (de) 3-arylaminocarbonyl-4-hydroxy-benzo eckige klammer auf b eckige klammer zu thiacyclohex(3)en-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE1948816C3 (de) Xanthenverbindungen und sie enthaltende Arzneimittel
DE3239220C2 (US06826419-20041130-M00005.png)
DE2823834C2 (de) Farnesylcarbonsäure-α-bisabololester, Verfahren zu dessen Herstellung und diesen enthaltendes Mittel
DE2708666C3 (de) Arzneimittel mit immunoregulativer und antiphlogistischer Wirkung
DE3718946A1 (de) Neue derivate der 4-phenyl-4-oxo-2-butensaeure, verfahren zu deren herstellung, deren verwendung als arzneimittel und diese enthaltende zusammensetzungen
DE2360475B2 (de) Arzneimittel zur Behandlung von Herzrhytmusstörungen
EP0036992B1 (de) Verwendung von S-Benzyl-3-benzylthiopropionthioat in Arzneimitteln
DE2448602C3 (de) N-Benzyl-2-[(m-trifluormethylthio) phenyl] -2-methoxy-äthylamin, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
DE2825322A1 (de) Alkylsubstituierte piperidin-n- oxide, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition